These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7927858)

  • 1. The hierarchical Bayesian approach to population pharmacokinetic modelling.
    Smith A; Wakefield J
    Int J Biomed Comput; 1994 Jun; 36(1-2):35-42. PubMed ID: 7927858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
    Dodds MG; Vicini P
    Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.
    Jelliffe RW; Schumitzky A; Van Guilder M; Liu M; Hu L; Maire P; Gomis P; Barbaut X; Tahani B
    Ther Drug Monit; 1993 Oct; 15(5):380-93. PubMed ID: 8249044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of dosage regimens: a multiple model stochastic control approach.
    Bayard DS; Milman MH; Schumitzky A
    Int J Biomed Comput; 1994 Jun; 36(1-2):103-15. PubMed ID: 7927848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.
    Wendling T; Dumitras S; Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):639-57. PubMed ID: 26231433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis.
    Vozeh S; Steiner C
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):511-28. PubMed ID: 3694495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples.
    Jelliffe RW; Maire P; Sattler F; Gomis P; Tahani B
    Int J Biomed Comput; 1994 Jun; 36(1-2):1-23. PubMed ID: 7927847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of population pharmacokinetic studies.
    Wakefield J; Rahman N
    Biometrics; 2000 Mar; 56(1):263-70. PubMed ID: 10783805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model.
    Sharifi-Malvajerdi S; Zhu F; Fogarty CB; Fay MP; Fairhurst RM; Flegg JA; Stepniewska K; Small DS
    Malar J; 2019 Jan; 18(1):4. PubMed ID: 30611278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Bayesian approach for PK/PD modeling with PD data below limit of quantification.
    Zhou H; Hartford A; Tsai K
    J Biopharm Stat; 2012; 22(6):1220-43. PubMed ID: 23075019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based approach to analyzing pulses in time series of hormone data.
    Horton KW; Carlson NE; Grunwald GK; Mulvahill MJ; Polotsky AJ
    Stat Med; 2017 Jul; 36(16):2576-2589. PubMed ID: 28393373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population modelling in drug development.
    Sheiner L; Wakefield J
    Stat Methods Med Res; 1999 Sep; 8(3):183-93. PubMed ID: 10636334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian hierarchical modeling of receptor occupancy in PET trials.
    Vandenhende F; Renard D; Nie Y; Kumar A; Miller J; Tauscher J; Witcher J; Zhou Y; Wong DF
    J Biopharm Stat; 2008; 18(2):256-72. PubMed ID: 18327720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of computers to pharmacokinetics, Bayesian approach and population pharmacokinetics].
    Hecquet B
    Bull Cancer; 1995 Dec; 82 Suppl 5():607s-611s. PubMed ID: 8680074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical methods for population pharmacokinetic modelling.
    Racine-Poon A; Wakefield J
    Stat Methods Med Res; 1998 Mar; 7(1):63-84. PubMed ID: 9533262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hierarchical model for integrating unsupervised generative embedding and empirical Bayes.
    Raman S; Deserno L; Schlagenhauf F; Stephan KE
    J Neurosci Methods; 2016 Aug; 269():6-20. PubMed ID: 27141854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.